Decreasing oxidative stress in response to treatment in patients with brucellosis: Could it be used to monitor treatment?

International Journal of Infectious Diseases

Volumn 15, Issue 5, 2011, Pages

  Karaagac, Leman ^a   Koruk, Suda Tekin ^a   Koruk, Ibrahim ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Brucellosis; Oxidative stress; Oxidative stress index (OSI); Therapy; Total antioxidant status (TAS); Total oxidant status (TOS)

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BRUCELLOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PATIENT MONITORING; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BRUCELLOSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; TREATMENT OUTCOME;

EID: 79954621217     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.01.009     Document Type: Article

References (29)

1. Pappas G., Papadimitriou P., Akritidis N., Christou L., Tsianos E.V. The new global map of human brucellosis. Lancet Infect Dis 2006, 6:91-99.
2. Franco M.P., Mulder M., Gilman R.H., Smits H.L. Human brucellosis. Lancet Infect Dis 2007, 7:775-786.
3. Jiang X., Baldwin C.L. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol 1993, 151:309-319.
4. Dieffenbach C.W., Tramont E.C., Plaeger S.F. Innate (general or nonspecific) host defense mechanisms. Principles and practice of infectious diseases 2010, 37-48. Elsevier Churchill Livingstone, Philadelphia. 7th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
5. Orem A., Efe H., Deger O., Cimsit G., Uydu H.A., Vanizor B. Relationship between lipid peroxidation and disease activity in patients with Behcet's disease. J Dermatol Sci 1997, 16:11-16.
6. Chambers J.C., Haskard D.O., Kooner J.S. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001, 37:517-520.
7. Halliwell B., Gutteridge J.M. Free radicals in biology and medicine 1999, Oxford Science Publications, London. 3rd ed.
8. Gorenek L., Acar A., Aydi{dotless}n A., Eyigun C.P., Cetinkaya A., Eken A., Sayal A. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Trans Med 2006, 4:25.
9. Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 45:819-828.
10. Harman D. Role of antioxidant nutrients in aging: overview. Age 1995, 18:51-62.
11. Erdogan S., Tosyali E., Duzguner V., Kucukgul A., Aslantas A., Celik S. Cisplatin reduces Brucella melitensis-infected cell number by inducing apoptosis, oxidant and pro-inflammatory cytokine production. Res Vet Sci 2010, 88:218-226.
12. Klebanoff S.J. Oxygen metabolism and toxic properties of phagocytes. Ann Intern Med 1980, 93:480-489.
13. Pappas G., Akritidis N., Bosilkovski M., Tsianos E. Brucellosis. N Engl J Med 2005, 352:2325-2336.
14. Food and Agricultural Organization-World Health Organization. FAO-WHO expert committee on brucellosis. 6th Report. WHO Tech Rep Ser 1986;740:56-7.
15. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37:277-285.
16. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004, 37:112-119.
17. Babior B.M. Phagocytes and oxidative stress. Am J Med 2000, 109:33-44.
18. Horoz M., Bolukbas C., Bolukbas F.F., Aslan M., Koylu A.O., Selek S., et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis 2006, 6:114.
19. Draganov D., Teiber J., Watson C. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Adv Exp Med Biol 2010, 660:89-97.
20. Bayraktar N., Kilic S., Bayraktar M.R., Aksoy N. Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study. J Clin Lab Anal 2010, 24:25-30.
21. Serefhanoglu K., Taksin A., Turan H., Timurkaynak F.E., Arslan H., Erel O. Evaluation of oxidative status in patients with brucellosis. Braz J Infect Dis 2009, 13:249-251.
22. Cao G., Prior R.L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998, 44:1309-1315.
23. Miyazawa T. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 1989, 7:209-217.
24. Janaszewska A., Bartosz G. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand J Clin Lab Invest 2002, 62:231-236.
25. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000, 29:1106-1114.
26. Roop R.M., Gaines J.M., Anderson E.S., Caswell C.C., Martin D.W. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol 2009, 198:221-228.
27. Rest R.F., Robertson D.C. Characterization of the electron transport system in Brucella abortus. J Bacteriol 1975, 122:139-144.
28. Sha Z., Stabel T.J., Mayfield J.E. Brucella abortus catalase is a periplasmic protein lacking a standard signal sequence. J Bacteriol 1994, 176:7375-7377.
29. Roop R.M., Gee J.M., Robertson G.T., Richardson J.M., Ng W.L., Winkler M.E. Brucella stationary-phase gene expression and virulence. Annu Rev Microbiol 2003, 57:57-76.